Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.
Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi manufactures and sells chemotherapy drug preparation kits, medical devices, and test kits in Turkey. The company offers OncoCare Monolitik, an automated chemotherapy drug preparation device; OncoCare Plus, a chemotherapy drug guide; OncoWaste and M-Waste, a hazardous waste sealing system, chemotherapy drugs, cephalosporins, penicillins,… Read more
Market Cap & Net Worth: Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM)
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (IS:ONCSM) has a market capitalization of $164.77 Million (TL5.84 Billion) as of March 19, 2026. Listed on the IS stock exchange, this Turkey-based company holds position #23557 globally and #332 in its home market, demonstrating a 7.27% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s stock price TL245.00 by its total outstanding shares 23850000 (23.85 Million).
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Market Cap History: 2023 to 2026
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s market capitalization history from 2023 to 2026. Data shows growth from $100.61 Million to $164.77 Million (121.76% CAGR).
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.42x
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s market cap is 0.42 times its annual revenue
0.73x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $100.61 Million | $240.51 Million | -$79.81 Million | 0.42x | N/A |
Competitor Companies of ONCSM by Market Capitalization
Companies near Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. in the global market cap rankings as of March 19, 2026.
Key companies related to Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Historical Marketcap From 2023 to 2026
Between 2023 and today, Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s market cap moved from $100.61 Million to $ 164.77 Million, with a yearly change of 121.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | TL164.77 Million | -6.84% |
| 2025 | TL176.88 Million | +147.88% |
| 2024 | TL71.36 Million | -29.08% |
| 2023 | TL100.61 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $164.77 Million USD |
| MoneyControl | $164.77 Million USD |
| MarketWatch | $164.77 Million USD |
| marketcap.company | $164.77 Million USD |
| Reuters | $164.77 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.